Ted P. Szatrowski
- Hematology top 0.5%
- Chronic Myeloid Leukemia Treatments 7
- Acute Myeloid Leukemia Research 4
- Geriatrics and Gerontology top 0.5%
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 6
-
- Cardiac, Anesthesia and Surgical Outcomes 5
-
- Aortic aneurysm repair treatments 6
- Aortic Thrombus and Embolism 5
- Prostate Cancer Treatment and Research 5
-
- Radiopharmaceutical Chemistry and Applications 4
Ted P. Szatrowski
41 papers receiving 10.7k citations
Hit Papers
Peers
Comparison fields: 5 of 170
- Hematology 1.5k
- Geriatrics and Gerontology 534
- Genetics 1.1k
- Critical Care and Intensive Care Medicine 414
- Cardiology and Cardiovascular Medicine 1.6k
Countries citing papers authored by Ted P. Szatrowski
This map shows the geographic impact of Ted P. Szatrowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ted P. Szatrowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ted P. Szatrowski more than expected).
Fields of papers citing papers by Ted P. Szatrowski
This network shows the impact of papers produced by Ted P. Szatrowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ted P. Szatrowski. The network helps show where Ted P. Szatrowski may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ted P. Szatrowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 86 | |
| 2 | 2018 | 37 | |
| 3 | Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemiabreakdown → | 2010 | 1103 |
| 4 | 2003 | 43 | |
| 5 | 2003 | 16 | |
| 6 | 2002 | 11 | |
| 7 | 1999 | 17 | |
| 8 | 1997 | 26 | |
| 9 | 1996 | 79 | |
| 10 | 1996 | 26 | |
| 11 | 1996 | 109 | |
| 12 | 1996 | 5 | |
| 13 | 1995 | 25 | |
| 14 | 1995 | 307 | |
| 15 | 1995 | 15 | |
| 16 | Validation of a combined comorbidity indexbreakdown → | 1994 | 5218 |
| 17 | 1994 | 60 | |
| 18 | 1993 | 4 | |
| 19 | 1982 | 163 | |
| 20 | 1982 | 125 |
About Ted P. Szatrowski
Ted P. Szatrowski is a scholar working on Hematology, Genetics and Developmental Neuroscience, having authored 41 papers that have together received 10.9k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Aortic aneurysm repair treatments (6 papers), Aortic Thrombus and Embolism (5 papers), Cardiac, Anesthesia and Surgical Outcomes (5 papers), Prostate Cancer Treatment and Research (5 papers), Radiopharmaceutical Chemistry and Applications (4 papers) and Acute Myeloid Leukemia Research (4 papers). The work is most often cited by research in Hematology (1.5k citations), Geriatrics and Gerontology (534 citations) and Genetics (1.1k citations). Ted P. Szatrowski has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Jeffrey P. Gold, Mary E. Charlson, Janey C. Peterson, Carl Nathan, M E Charlson, Pamela Williams‐Russo, Gregg S. Hartman, Ross L. Prentice, Mark W. Mason and Hiroo Kato. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.